IL6 and in situ carcinoma: Tangeretin at a dose of 20 mg/kg suppressed increment in IL‐1β and IL‐6 levels more crucially than CIS at a dose of 10 mg/kg (p < 0.001 and p < 0.0001, respectively) (Figure 5B,C).